Stay updated on DETERMINE-preserved: Dapagliflozin Clinical Trial
Sign up to get notified when there's something new on the DETERMINE-preserved: Dapagliflozin Clinical Trial page.
Latest updates to the DETERMINE-preserved: Dapagliflozin Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.0%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedLocations section updated to include multiple US states and Canadian provinces, with a new revision tag (v3.3.3).SummaryDifference1%
- Check53 days agoChange DetectedPubMed publication note wording updated to indicate automatic filling from PubMed and the revision label upgraded to v3.3.2; the previous PubMed note and version v3.2.0 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check61 days agoChange DetectedRemoved the government funding status notice, which does not affect study content or data; the rest of the page content and location listings remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check82 days agoChange DetectedNo significant content changes were observed on the Study Details page; any differences are likely minor formatting or layout adjustments and do not affect the study information.SummaryDifference0.2%
- Check104 days agoChange DetectedUpdated operating-status notice and version 3.2.0; removed version 3.1.0.SummaryDifference3%
Stay in the know with updates to DETERMINE-preserved: Dapagliflozin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DETERMINE-preserved: Dapagliflozin Clinical Trial page.